Figure 3From: Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysisMedian overall survival for patients undergoing traditional TACE (---) and for those who were treated with pTACE (---------) (46 vs 14 months, p = 0.0002). Only patients receiving exclusive TACE were considered.Back to article page